Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients

Clinical trial NCT00037609 · COMPLETED

Trial details

NCT number: NCT00037609
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Metastases, Neoplasm

Start date: 2001-01-01
Primary completion: 2003-02-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.